1. cis-Diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II);Fichtinger-Schepman;Cancer Res.,1987
2. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes;Shen;Pharmacol. Rev.,2012
3. The role of DNA mismatch repair in platinum drug resistance;Fink;Cancer Res.,1996
4. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates;Kelland;Cancer Res.,1992
5. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines;Mistry;Br. J. Cancer,1991